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Aims: The Prevention of Lower Urinary Tract Symptoms (PLUS) Research
Consortium was established by the National Institutes of Health in 2015 to expand
research beyond the detection and treatment of lower urinary tract symptoms (LUTS)
to the promotion and preservation of bladder health and prevention of LUTS in girls
and women. While many multi-disciplinary scientific networks focus on pelvic floor
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dysfunction and LUTS, the PLUSConsortium stands alone in its focus on prevention.
This article describes the PLUS approach to developing a conceptual framework to
guide the Consortium's initial prevention research agenda.
Methods: The conceptual framework was informed by traditional social ecological
models of public health, biopsychosocial models of health, Glass and McAtee's
Society-Behavior-Biology Nexus, and the World Health Organization's conceptual
framework for action on the social determinants of health.
Results: The PLUS conceptual framework provides a foundation for developing
prevention interventions that have the greatest likelihood of promoting and preserving
bladder health among diverse populations.
Conclusions: PLUS Consortium work is premised on the notion that programs,
practices, and policies designed to promote health will have optimal impact if the
conceptual foundation upon which efforts are based is comprehensive and informed
by multiple disciplines. The PLUS conceptual framework is broadly applicable to
domains of health that have historically focused on the treatment of illness and
symptoms rather than the promotion of health. It is also applicable to domains of
health that have been examined from a predominantly biological or social ecological
perspective, without integration of both perspectives.
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1 | INTRODUCTION
The promotion of health and prevention of disease are
essential components of public health.1 In many domains of
health, however, research and practice are focused primarily
on the identification and treatment of disease rather than the
promotion of public health. The lower urinary tract is one
such domain. Lower urinary tract symptoms (LUTS)
encompass a variety of bothersome storage and emptying
symptoms, including urgency urinary incontinence (ie, strong
urge “to go” and losing urine before reaching a toilet), stress
urinary incontinence (eg, losing urine with physical activity
or increases in abdominal pressure such as a cough or sneeze),
frequent and/or urgent urination, nocturnal enuresis (ie, bed-
wetting), difficulty urinating, dribbling after urination, and
bladder or urethral pain before, during, or after urination.2,3
LUTS are extremely common, with more than 200 million
people worldwide and over 15% of women aged 40 years or
older suffering from urinary incontinence.4,5 Overactive
bladder (OAB), a subset of LUTS, is characterized by urinary
urgency, with or without urgency incontinence, and usually
with frequent daytime and nighttime urination.3 In the United
States (U.S.) and Europe, prevalence of OAB in adults has
been estimated at approximately 16%.6,7 Substantial public
and private investments have been made to diagnose and treat
conditions associated with LUTS. For example, there are
currently over 20 medications for management of OAB;
historically, there have been over 200 different surgical
procedures for stress urinary incontinence.8,9 The total U.S.
economic burden, including lost work productivity, of OAB
with urgency urinary incontinence was estimated to be $65.9
billion in 2007, with a projected annual estimate of $82.6
billion by 2020.10
Prevention of LUTS is particularly important for girls and
women. Women are 2-3 times more likely to experience
urinary incontinence and four timesmore likely to experience a
urinary tract infection in comparison to men.11–14 In a large,
population-based sample of individuals from theUnited States,
UnitedKingdom, and Sweden, 71%ofmen and 75%ofwomen
reported at least one LUTS.15 Women are at higher risk for
specific LUTS thanmen due to the anatomy and physiology of
the female urogenital system.16 Women's hormonal milieu,
experiences during pregnancy and childbirth, and gendered
societal experiences are additional contributors.16,17 For
example, women may encounter greater barriers to toileting
in public spaces (accessibility, privacy, safety, and cleanli-
ness).17 While men report more problems than women with
bladder emptying, women report more problems with storage
and overall LUTS.18 Moreover, LUTS tend to begin earlier in
the life course for women than for men.7,16
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The prevalence and incidence of LUTS among women
varies across the life course. Estimates of urinary incontinence
in women range from 10% to 50%, depending on the definition
of incontinence and age of the population being studied.16,19
Generally, LUTS in girls include urinary tract infections and
nocturnal enuresis.20,21 In contrast, LUTS in women predomi-
nantly include stress urinary incontinence during the repro-
ductive years; urgency and mixed urinary incontinence with
increasing age4; and urinary tract infections aftermenopause.22
Early prevention of LUTS is important to public health
promotion, as the early experience of LUTS may predispose
girls and women to reoccurrence, worsening, or new onset of
LUTS with age.22,23 Prevention of LUTS is important to the
promotion of both physical health and emotional well-being.
Anxiety or depression is reported bymore than 50% of women
with LUTS, and social isolation is common.24,25 Thus, LUTS
have substantial impact on the health and quality of life of girls
and women across the life course and are important to prevent
at all ages.
1.1 | Challenging the status quo
Traditionally, LUTS have been viewed bywestern health care
providers from a medical model perspective that promotes a
reactive response. In this model, girls or women develop
symptoms, seek help, and receive treatment that may or may
not lead to cure or amelioration of symptoms. Despite the
medical model perspective, LUTS have been largely under-
diagnosed and undertreated, with up to 75% of women with
urinary incontinence not seeking care.26 This may be
attributed to a sense of embarrassment or stigma that hinders
health care seeking and open communication, or to lack of
knowledge on the part of affected women or providers,
including the misperception that LUTS are a normal part of
being female or aging.27–29 Over the past several decades,
there has been a proliferation of advertising campaigns for
products designed to help women manage LUTS through
pharmaceuticals and incontinence aids.30,31 While advertise-
ments for LUTS products may help to reduce stigma,32 they
may also serve to normalize the experience of LUTS.Women
may approach their providers for medication to treat LUTS, or
they may be misled to think their symptoms can only be
managed by incontinence containment products. Thus, both
the medical model and profit-incentivized industries 33 have
contributed to societal norms focused on the treatment and
self-management of LUTS rather than prevention.
Additionally, financial incentives for health care systems
and providers have been linked to the identification and
treatment of disease, rather than the promotion of health and
prevention of disease.34While investment in the prevention of
other prevalent conditions such as obesity,35 cardiovascular
disease,36 colorectal cancer,37 and infectious diseases38 has
increased, investment in the prevention of LUTS has lagged.
A small body of literature has identified potentially
modifiable risk factors for LUTS and examined the impact
of prevention strategies39–42; this literature has begun to
expand the focus of research and practice toward the
prevention of LUTS among girls and women. However, to
shift the prevailing health care paradigm to an emphasis on
prevention, coordinated efforts on the part of scientists and
health care professionals are needed.
2 | MATERIALS AND METHODS
The Prevention of Lower Urinary Tract Symptoms (PLUS)
Research Consortium was established in 2015 to expand
research beyond the detection and treatment of LUTS to the
promotion and preservation of bladder health and prevention
of LUTS in girls and women.43While many multidisciplinary
research networks focus on pelvic floor dysfunction and
LUTS, the PLUS Consortium stands alone in its focus on
prevention. The PLUS Consortium is comprised of a
transdisciplinary network of professionals, including com-
munity advocates, health care professionals, and scientists
specializing in pediatrics, adolescent medicine, gerontology
and geriatrics, nursing, midwifery, behavioral medicine,
preventive medicine, psychiatry, neuroendocrinology, repro-
ductive medicine, female pelvic medicine and reconstructive
surgery, urology, infectious diseases, clinical and social
epidemiology, prevention science, medical sociology, psy-
chology, women's studies, sexual and gender minority health,
community-engaged research, community health promotion,
scale development, research methods, and biostatistics. Early
conversations between network members acknowledged the
diversity of girls andwomenwith respect to sexual orientation
and gender identity (SOGI). Members agreed to include
SOGI measures in PLUS studies and to develop inclusion/
exclusion criteria for cisgender and transgender individuals
that fit the scientific objectives of each study.
To shift research, practice, and policies to a focus on
health, the PLUS Consortium identified two initial tasks that
it pursued in parallel. First, the Consortium drafted a research
definition of bladder health.44 Consistent with the World
Health Organization's definition of health,45 the PLUS
Consortium conceptualizes bladder health as “a complete
state of physical, mental, and social well-being related to
bladder function, and not merely the absence of LUTS,” with
function that “permits daily activities, adapts to short term
physical or environmental stressors, and allows optimal well-
being (eg, travel, exercise, social, occupational, or other
activities).” Second, the Consortium adopted a prevention
science paradigm and developed a conceptual framework to
guide the Consortium's initial prevention research agenda.
The Consortium began this task by establishing a shared
understanding of prevention science among its diverse
members. The Consortium then drew from separate, but
BRADY ET AL. | 2953
complementary theoretical traditions and contemporary
writings to develop the PLUS conceptual framework. The
purpose of this manuscript is to describe the PLUS approach
in developing a conceptual framework to guide the
Consortium's initial prevention research agenda.
3 | RESULTS
3.1 | Adoption of a prevention science
paradigm
An underlying premise of prevention science is that one must
understand what leads to disease and how disease can be
prevented in order to promote and preserve health. Prevention
science involves the systematic study of potential precursors
to human dysfunction and health, termed risk and protective
factors, respectively.46,47 Risk factors are those attributes,
characteristics, or exposures of an individual that increase the
likelihood of developing a disease. In contrast, protective
factors enhance health and lessen the likelihood that
dysfunction will occur in response to risk factors. Risk and
protective factors at different levels of social ecology have
also been referred to as social determinants of health.48,49
Prevention scientists conduct etiologic studies to identify risk
and protective factors across different levels of biology and
the social ecology that surrounds individuals.46,47 They also
develop and test prevention interventions aimed at modifying
risk and protective factors, with the goal of promoting health
and preventing or moderating major dysfunction before onset
of disease or disorder. Prevention science applies a life course
developmental perspective to etiologic research and rigorous
intervention methodology.50 Dissemination of findings are
expected to impact health promotion programs, practices, and
policies, and in turn, the health of populations across the life
course.
3.2 | Development of the PLUS conceptual
framework
Developing a conceptual framework that encompasses all
facets of social ecology, integrates biology with social
ecology, and emphasizes a life course perspective is key to the
adoption of a prevention science paradigm. The PLUS
conceptual framework is informed by traditional social
ecological models of public health and biopsychosocial
models of health. It also integrates contemporary conceptu-
alizations of public health that explicitly acknowledge the role
of societal structures in creating health inequities—namely,
Glass and McAtee's51 Society-Behavior-Biology Nexus and
the World Health Organization's Conceptual Framework for
Action on Social Determinants of Health.52 In the sections
below, each model and framework that informed the PLUS
conceptual framework is reviewed. These resources may
serve as valuable tools in effecting other paradigm shifts in
health among scientists, practitioners, and policymakers.
Social ecological conceptualizations of public health
situate individuals within environments of interrelated,
interacting, and nested spheres of influence on health and
health behavior. Social ecological models traditionally draw
from theories of individual behavior and interpersonal
relations, which may be thought of as proximal social
influences, as well as sociological structures such as
institutions, communities, cultures, and policy landscapes,
which may be thought of as distal social influences.53 Social
ecological models hail from the work of behavioral scientists
and systems theorists, including Brofenbrenner's pioneering
conceptualization of systems at multiple levels of social
ecology that influence child development.54 A social
ecological conceptualization allows public health scientists
and practitioners to consider individuals within an ecosystem
of risk and protective factors beginning with the intrapersonal
level (genetics, psychology, health status) and extending
outward to the interpersonal (family, peer, partner influence),
institutional (school, work, health care system), community
(cultural norms), and societal (policies, laws, economics)
levels. By identifying prevention opportunities at multiple
levels of influence, public health professionals aim to
effectively promote both individual and population health.
Social ecological models have increasingly been applied in
health promotion and intervention contexts over the past
40 years.55 A variety of factors have led to this trend, including
increased attention to social determinants of health and health
inequities; recognition of the limitations of focusing only on
linear causality via proximal individual-level risk factors; and
frustration with individual behavior change interventions that
donot account for contextual influences.55–58 Social ecological
approaches have been applied most often in public health
interventions to change behaviors such as nutrition intake,
physical activity, and smoking.59 For example, a behaviorally
focused ecologic approach to improve nutrition and physical
activity within a population might include education for
individuals; modifying home cooking practices for families;
engaging schools and workplaces to support access to fresh,
healthy food options; fostering healthy norms and ensuring
access to healthy foods in the community; and taxing unhealthy
foods and funding the creation of public exercise spaces. Social
ecological approaches have been utilized less often to
understand physiologic dysfunction, such as LUTS. Public
health scientists and organizations increasingly value multi-
level approaches to public health promotion that address a
broad array of influences, fromgenes tomacroeconomics.60–62
As behavioral scientists began to widen the lens of social
ecology to explain health and disease, physicians and other
health care professionals began to integrate biology and social
context. Roughly 40 years ago, biopsychosocial (BPS)models
of health were proposed as an alternative to the prevailing
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biomedical model.63 Engel advocated a new multilevel
systems approach that would acknowledge not only the
organic or biological basis of disease, but also “the patient, the
social context in which he lives, and the complementary
system devised by society to deal with the disruptive effects
of illness.” Essentially holistic, the basic assumption of the
BPS model is that all illness is a complex reciprocal
interaction of biological, psychological, and social factors.64
The BPSmodel, similar to other social ecological models, has
been proposed as a framework for understanding conditions
that are determined by interrelated, interacting risk and
protective factors, such as multimorbidity65 and the obesity
epidemic.66 Application of the BPS model is not without
criticism, however. For example, Henningsen67 observed that
attention to the “bio” component in the BPS model has grown
at the expense of “psychological” and “social” components,
potentially because biologically based treatments are pre-
ferred by many medical practitioners and confer greater
economic advantage to institutions. Further, Henningsen
noted that a focus on “psychosocial” determinants of health
proximal to the individual has resulted in missed oppor-
tunities to focus on important “sociocultural” determinants of
health that are distal to the individual.67
3.2.1 | Glass and McAtee's Society-Behavior-
Biology Nexus
Over a decade ago, Thomas Glass and Matthew McAtee51
developed the Society-Behavior-Biology Nexus to integrate
social ecological and biological influences on health. Their
model depicts nested spheres of influences both within and
outside of the individual, who moves through time from
infancy to old age. The Society-Behavior-Biology Nexus
situates the individual within nested systems of social
organization, ranging outward to encompass the micro-level
(family, social networks), mezzo-level (schools, worksites,
communities, health care systems), macro-level (states,
nations), and global level (geopolitics, economic and
environmental dynamics). Unlike most social ecological
models, the Society-Behavior-Biology Nexus explicitly
highlights nested systems of biological organization within
the individual, ranging inward to encompass multi-organ
systems, cellular level influences, sub-cellular/molecular
level influences, and the genomic substrate.
The Society-Behavior-Biology Nexus integrates social
ecology and biology through the concepts of embodiment68
and gene-by-environment interactions. Social ecological risk
and protective factors, which Glass and McAtee51 framed as
societal constraints and opportunities, can become embodied
with respect to biological function. Expression of biologically
based predispositions toward health or disease can also be
triggered by specific social ecological contexts. Glass and
McAtee51 developed the concept of a risk regulator to
emphasize societally imposed constraints against and
opportunities for health. Risk regulators include material
conditions; discriminatory practices, policies, and attitudes;
neighborhood and community conditions; behavioral norms,
rules, and expectations; conditions of work; and laws,
policies, and regulations. Risk regulators can influence health
and disease through multiple, potentially complex pathways
over time. For example, different risk and protective factors
might accumulate, influence one another, and influence
health outcomes in a bi-directional fashion. Identifying the
initial cause of a health effect is less important than knowing
that a cluster of risk and protective factors appears to play a
causal role in the maintenance of health, or the generation or
exacerbation of poor health. For this reason, prevention
programs must address societally imposed constraints on
health early in life and throughout the life course in order to be
effective.
The PLUS Consortium chose to adapt Glass and
McAtee's51 model because it stimulates thought about a
broad spectrum of factors that may influence health across the
life course. Figure 1 depicts a condensed version of the PLUS
conceptual framework to guide studies investigating the
etiology and prevention of LUTS and promotion of bladder
health. This framework shows how environmental risk and
protective factors (eg, constrained or unconstrained toilet
access) can become embodied in the structure and functioning
of biological systems that affect bladder health and the
development of LUTS. The framework also includes the
potential for gene-by-environment interactions. Genetic and
biological predispositions toward bladder health and the
development of LUTS may be more likely to be expressed in
specific social and environmental contexts. Throughout the
life course, individual behavior is a critical determinant of
bladder health and LUTS. Whereas Glass and McAtee51
depicted behavior within an arrow representing the life
course, the PLUS Consortium depicts bladder health and
LUTS within this arrow (see center of Figure 1). Behavior is
grouped with cognitive, affective, and psychosocial attributes
of the individual. Prevention strategies can target specific
social ecological determinants of bladder health and LUTS, as
well as behaviors that can ameliorate genetic and biological
vulnerabilities.
3.2.2 | World Health Organization's (WHO)
Conceptual Framework for Action on Social
Determinants of Health
Glass and McAtee's51 Society-Behavior-Biology Nexus
draws attention to the role of risk regulators in creating
health inequities. However, the framework is not explicit
about how risk regulators are created and maintained. The
World Health Organization (WHO) established a Commis-
sion on Social Determinants of Health to summarize evidence
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for how the structure of societies—through governance,
policies, culture, and values—determines the health of
populations.52 Namely, a society stratifies its population
according to income, education, occupation, gender, race,
ethnicity, and other factors. From these social stratifications,
social hierarchies result. Position within the social hierarchy
in turn shapes specific social determinants of health. Thus, the
WHO framework separates structural determinants of health
inequities, the distal factors rooted in a society's political,
economic, and social structures (eg, macroenonomic and
public policies), from social determinants of health, a more
commonly understood term that refers to proximal factors
rooted in one's social position (eg, living and working
conditions). The WHO framework asserts that a society
produces health and disease among its citizens. The
framework also asserts that policymakers bear responsibility
for creating and maintaining health equity among popula-
tions, as well as redressing the structural factors that produce
under-resourced communities and health inequities.
Inclusion of the WHO perspective within the PLUS
conceptual framework has allowed the Consortium to
intentionally consider issues of health equity and social
justice in its development of a population-based prevention
science agenda. Health disparities69 are defined as differ-
ences in health that are closely linked with economic, social,
or environmental disadvantage. Whereas a health disparity
highlights no explicit cause for the disparity, a health inequity
highlights a difference in health that is imposed by society and
is unnecessary, avoidable, and unjust.70,71 The WHO
framework highlights the importance of policy-based
interventions as part of a multi-level population-based
prevention strategy. Insufficient attention to policies that
impact the conditions in which people live and their
opportunities to be healthy could inadvertently generate or
widen health inequities over time and across generations. This
can occur even when the health of all communities is
improving. The WHO framework can enhance the impact of
the PLUS Consortium by encouraging prevention interven-
tions at distal, structural levels (eg, federal policies) rather
than solely focusing on individual and proximal levels of
influence in the environment (eg, the built environment).
While prevention interventions that aim to influence social
determinants of health typically function at the community
level, prevention interventions at the structural level aim to
change a society's political, economic, and social systems—
the factors that give rise to disadvantageous social groupings
and socioeconomic positions.
3.3 | Applying the PLUS conceptual
framework to build a prevention research
agenda
Initial PLUS Consortium activities were designed to engage
members in a series of analytic processes to develop the
PLUS conceptual framework and inform the Consortium's
initial prevention research agenda. First, Consortium
FIGURE 1 Prevention of Lower Urinary tract Symptoms (PLUS) among girls and women: A conceptual framework adapted from Glass and
McAtee51
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members identified levels of social ecology and biology that
are relevant to the PLUS Consortium. As shown in Table 1
(see columns), Consortium members divided individual-
level risk and protective factors into those that were
biological (biology/body) and those that were cognitive,
affective, or behavioral (mind/behavior). The Consortium
separately considered interpersonal risk and protective
factors for LUTS and bladder health. Because of the
Consortium's life course perspective, interpersonal factors
include the influence of parents and other family members
during early life (eg, toileting techniques and habits), as well
as peers and partners later in life. Consistent with social
ecological models of public health andGlass andMcAtee's51
notion of risk regulators, the Consortium focused on
institutional factors that may influence LUTS and bladder
health (eg, access to bathroom facilities within schools and
workplaces; cleanliness, privacy, and safety of facilities).
Consistent with the WHO distinction between social
determinants of health and structural determinants of health
inequities,52 the Consortium focused on community and
societal level factors that may influence LUTS and bladder
health (eg, neighborhood safety and cohesion; public
bathroom infrastructure and access; policies and laws
governing control over fluid intake and voiding opportunity
in schools and workplaces).
Once the Consortium had identified different levels of
biology and social ecology that may influence LUTS and
bladder health, members focused on generating potential
risk and protective factors within each level of the
framework. Potential factors were generated based on
existing literature, theories of health and human behavior,
and clinical and professional observation. The nested levels
of influence within and outside of the individual served as
prompts to consider risk and protective factors that may have
been outside of one's area of expertise. A conceptual
framework encapsulates what is possible to study; thus, it is
intentionally comprehensive. The Consortium generated
over 600 potential risk and protective factors. While such an
exercise and resulting product appeared overwhelming, this
activity was critical to building a prevention science
research agenda. A systematic approach to studying
potential precursors to LUTS and bladder health ideally
begins with a comprehensive list of all that is possible to
study.
PLUS Consortium members next engaged in an
activity to prioritize risk and protective factors for study.
By design, the interests of individual research members
and teams within the Consortium are broad. It is thus not
surprising that from the original list of over 600 potential
risk and protective factors, over 400 factors remained after
initial prioritization (see supplemental appendix). Priori-
tized risk and protective factors were clustered into eight
broad research themes to facilitate the selection of factorsT
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for study. Table 1 organizes several of the PLUS
Consortium's prioritized factors by research theme (see
rows) and level of ecology (see columns).
The organization of risk and protective factors by research
theme and level of ecology can serve as a tool to generate
study-specific conceptual models. Whereas a conceptual
framework encapsulateswhat is possible to study, a conceptual
model encapsulates what a research team has prioritized and
chosen to study.72 A conceptual model shows the mechanisms
by which specific risk and protective factors may be linked
with health outcomes. Figure 2 depicts one example of a
conceptual model that emerged through discussion. In this
example, girls who attend schools and women who work in
occupational settings where policies, norms, and practices
prohibit timely access to bathrooms (ie, autonomy)may restrict
their fluid intake and hold urine until it is painful or urine
leakageoccurs. Institutional policies, norms, andpracticesmay
also impact perceived privacy, safety, and cleanliness of
bathrooms, which in turn may lead to fluid restriction
and delayed voiding. In addition, perceived cleanliness
of bathrooms may lead to adjustment of toileting position
(eg, hovering versus sitting). Behavioral habits (eg, fluid
restriction, delayed voiding, hovering)may in turn increase the
likelihood of adverse health outcomes (see Figure 2).
In addition to identifying and organizing potential
determinants of LUTS and bladder health according to
different levels of the ecological and biological systems
depicted in Figure 1,Consortiummembers delineated different
life stages that are relevant to PLUS (see Table 2).73–75
The PLUS Consortium acknowledges variation within a
chronological age period and views developmental status and
events related to the lower urinary tract as more relevant to
bladder health than chronological age. Developmental stages
are delineated by chronological age to provide a rough index of
who may be impacted by specific aspects of social ecology.
Table 2 shows how the social ecological context of a female
individual may vary by life stage. A comprehensive list of all
contextual factors that vary by development is not shown.
Rather, Table 2 summarizes factors judged by the PLUS
Consortium to be particularly relevant to LUTS and bladder
health. Table 2 illustrates the importance of studying girls and
women across the life course.
4 | DISCUSSION
As the PLUS Consortium evolves, its conceptual framework
and supporting materials will be modified as new terminol-
ogy, concepts, and risk and protective factors for LUTS
and bladder health are identified. Thus, the Consortium
intends to be open and agile in its ability to respond to new
developments in science and society.
The Consortium has begun to develop a prevention
research agenda that is applying the PLUS conceptual
framework presented in this manuscript. The framework is
not only of value in selecting risk and protective factors that
may influence LUTS and bladder health, but also in selecting
potential confounders—those variables that may influence
both the hypothesized predictor and outcome variable,
resulting in a spurious (false) association.76 By identifying,
FIGURE 2 Sample conceptual model: Mechanisms by which schools and workplaces may influence bladder health and LUTS among girls
and women (adapted from PLUS conceptual framework and Wang and Palmer)82
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measuring, and statistically adjusting for potential confound-
ers in analyses, a research team can better isolate the
contribution of hypothesized risk and protective factors to
LUTS and bladder health. Confidence in results is enhanced
when multiple studies—with different samples, study
designs, and analytic approaches—support the causal role
of hypothesized risk and protective factors.
The PLUS research agenda is expected to be implemented
in a manner that corresponds to phases of translational
research. Fishbein et al77 recently refined and extended the
phases of basic science translational research for application
to prevention science. Current efforts of the Consortium
correspond to the first phase, discovery science (T0), which
involves the identification of risk and protective factors to
inform future prevention efforts. Remaining phases of
prevention science translational research77 correspond to
future efforts of the PLUS Consortium, including methods
and program development (T1), efficacy and effectiveness
trials (T2), and real world applications and dissemination
(T3). The time period necessary to demonstrate efficacy and
effectiveness of prevention interventions will likely depend
on a number of considerations, including the risk or protective
factor being targeted (eg, school or workplace policy
governing access to toilets, family- or peer-based toileting
norms, individual toileting behaviors); the outcome being
examined (eg, continence, UTI); the population of girls or
women being studied (eg, those who are asymptomatic vs
symptomatic, corresponding to primary vs secondary
prevention); and the period of time during which
the LUTS under study typically develop. While it is difficult
to anticipate the specific amount of time necessary to
demonstrate efficacy or effectiveness of a prevention
intervention, allowing 6 months to a year would be a
reasonable initial approach. Degree of bladder health and
LUTS should be examined, as opposed to an outcome that
does not facilitate the identification of promising trends.
In addition, it is important to examine whether the prevention
intervention successfully altered the targeted risk and
protective factors.
It is anticipated that phases T0-T3 will be followed by
scaling and policy reform (T4), which involves wide-scale
implementation, adoption, and institutionalization of new
guidelines, practices, and policies.77 The final phase of
prevention science translational research is globalization and
public opinion (T5), which involves the cultivation of a
fundamental and universal change in social systems,
including policies and norms that promote bladder health.77
Phases T4 and T5 will allow the PLUS Consortium to impact
social determinants of health, and potentially, structural
determinants of health inequities.52 In addition to policy
changes within organizations, legislation may be enacted to
ensure that all members of a diverse society are embedded
within institutions and communities that promote health. This
approach is consistent with calls to ensure “potty parity”with
respect to the planning and design of public restrooms.78
While the PLUS conceptual framework and prevention
science paradigm promotes rigorous science, additional
approaches are needed to ensure that theConsortium's research
is informed by the lived experiences of girls and women and
that resulting prevention interventions are likely to be well-
received. For this reason, the PLUS Consortium is examining
the extent to which community engagement principles can be
incorporated into initial and ongoing activities. Authentic
engagement with community stakeholders allow scientists and
practitioners to mobilize resources, influence systems,
and serve as catalysts for changing programs, practices, and
policies.79–81
5 | CONCLUSIONS
The PLUS Research Consortium was established by the
National Institutes of Health in 2015 to expand research
beyond the detection and treatment of LUTS to the promotion
and preservation of bladder health and prevention of LUTS.
The PLUS Consortium is tasked with significantly expanding
the prevention science literature on LUTS and promotion of
bladder health. PLUS Consortium work is premised on the
notion that programs, practices, and policies designed to
promote health will have optimal impact if the conceptual
foundation upon which efforts are based is comprehensive and
informed bymultiple disciplines. The tables and figures of this
manuscript are tools that can be used to select, prioritize, and
model risk and protective factors for study by all scientists
interested in bladder health. The PLUS conceptual framework
provides a foundation for developing prevention interventions
that have the greatest likelihood of promoting and preserving
bladder health among diverse populations.
While the Consortium's work is focused on prevention of
LUTS and promotion of bladder health, the PLUS conceptual
framework is broadly applicable to any domain of health that
has historically focused on the treatment of illness and
symptoms rather than the promotion of health. It is also
broadly applicable to domains of health that have been
examined from a predominantly biological or social ecologi-
cal perspective, without integration of both perspectives.
Work of the PLUS Consortium will contribute to the rich,
evolving history and practice of prevention science, as well as
the conceptualization of public health.
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